SCHEMBL29488482

SCHEMBL29488482

O=C(CCCC/C=C(\COc1cccc2ccccc12)C(=O)NC1CCCCC1)NO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.49
▸ HDAC6 Q9UBN7 6/20 0.49
▸ HDAC3 O15379 3/20 0.49
▸ HDAC2 Q92769 3/20 0.49
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ ADAMTS4 O75173 1/20 0.43
▸ ADAMTS5 Q9UNA0 1/20 0.43
▸ EPHX1 P07099 1/20 0.43
▸ HPGD P15428 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ OGG1 O15527 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1306703 1.00 HDAC1 (0.49) HDAC1HDAC6HDAC3HDAC2KMT2A
SCHEMBL1306701 1.00 HDAC1 (0.49) HDAC1HDAC6HDAC3HDAC2KMT2A
SCHEMBL1306742 0.91 HDAC1 (0.41) HDAC1HDAC6HDAC3HDAC2KMT2A
SCHEMBL29488469 0.91 HDAC1 (0.41) HDAC1HDAC6HDAC3HDAC2KMT2A
SCHEMBL1306745 0.91 HDAC1 (0.41) HDAC1HDAC6HDAC3HDAC2KMT2A
SCHEMBL1308003 0.91 KMT2A (0.48) KMT2AMEN1ALDH1A1ADAMTS4ADAMTS5
SCHEMBL1308006 0.91 KMT2A (0.48) KMT2AMEN1ALDH1A1ADAMTS4ADAMTS5
SCHEMBL1308300 0.89 MEN1 (0.45) KMT2AMEN1ALDH1A1ADAMTS4ADAMTS5
SCHEMBL1308296 0.89 MEN1 (0.45) KMT2AMEN1ALDH1A1ADAMTS4ADAMTS5
SCHEMBL1306054 0.89 P2RX3 (0.39) HDAC1HDAC6HDAC3HDAC2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-112930177-B Pharmaceutical compositions containing alkylcarbamoyl naphthoyl octenoyl hydroxyamide phosphate, tartrate or combinations thereof and methods of making the same 晶体基因技术株式会社 2024-01-30 — — CN disclosed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
CN-110740989-B Pharmaceutically acceptable salts of alkylcarbamoylnaphthoxyoctenoylhydroxyamides or derivatives thereof and process for preparing the same 晶体基因技术株式会社 2022-03-08 — — CN disclosed
Send feedback